LISDEXAMFETAMINE IN THE NATION: A DETAILED OVERVIEW

Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug recognized in Canada for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children and people. It's functions as a prodrug, meaning it’s dormant until broken down by the body, releasing dextroamphetamine gradually over an exten